Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNH
3826
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.37M | ﹤0.01% |
23,473
-38,424
| -62% | -$2.07M |
|
3827
World Acceptance Corp
WRLD
$897M
| $1.37M | ﹤0.01% |
20,852
-13,406
| -39% | -$838K |
|
3828
Virtus Biotech Clinical Trials ETF
BBC
$48.6M
| $1.36M | ﹤0.01% |
31,551
+12,587
| +66% | +$482K |
|
3829
Cathay General Bancorp
CATY
$4.29B
| $1.36M | ﹤0.01% |
51,779
+10,245
| +25% | +$261K |
|
3830
Invesco International BuyBack Achievers ETF
IPKW
$555M
| $1.36M | ﹤0.01% |
46,967
-69,609
| -60% | -$1.85M |
|
|
SCX
3831
DELISTED
The L.S. Starrett Company
SCX
| $1.35M | ﹤0.01% |
399,741
-8,421
| -2% | -$28.7K |
|
3832
Heron Therapeutics
HRTX
$95.5M
| $1.35M | ﹤0.01% |
91,795
-429,386
| -82% | -$7.05M |
|
3833
PC Connection
CNXN
$2.17B
| $1.35M | ﹤0.01% |
29,046
+1,199
| +4% | +$50.5K |
|
|
GER
3834
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
| $1.35M | ﹤0.01% |
177,877
-297,364
| -63% | -$2.34M |
|
3835
Fulton Financial
FULT
$4.73B
| $1.34M | ﹤0.01% |
127,632
+4,474
| +4% | +$48.5K |
|
3836
iShares iBonds Dec 2027 Term Muni Bond ETF
IBMP
$654M
| $1.34M | ﹤0.01% |
50,037
+21,998
| +78% | +$580K |
|
3837
First Horizon
FHN
$12.4B
| $1.34M | ﹤0.01% |
134,458
-264,816
| -66% | -$2.41M |
|
3838
Invesco S&P SmallCap Financials ETF
PSCF
$27.9M
| $1.34M | ﹤0.01% |
34,025
-8,030
| -19% | -$299K |
|
|
CCRN
3839
DELISTED
Cross Country Healthcare
CCRN
| $1.33M | ﹤0.01% |
216,541
-374,000
| -63% | -$2.29M |
|
3840
Cars.com
CARS
$662M
| $1.33M | ﹤0.01% |
230,783
+113,242
| +96% | +$626K |
|
|
ACV
3841
Virtus Diversified Income & Convertible Fund
ACV
$283M
| $1.33M | ﹤0.01% |
57,518
+12,475
| +28% | +$266K |
|
|
MORF
3842
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.32M | ﹤0.01% |
48,965
+47,887
| +4,442% | +$896K |
|
|
FRBK
3843
DELISTED
Republic First Bancorp Inc
FRBK
| $1.32M | ﹤0.01% |
543,561
-97,783
| -15% | -$225K |
|
3844
Columbia Financial
CLBK
$1.12B
| $1.32M | ﹤0.01% |
94,711
+41,939
| +79% | +$586K |
|
|
RUBY
3845
DELISTED
Rubius Therapeutics, Inc
RUBY
| $1.32M | ﹤0.01% |
220,195
+158,621
| +258% | +$936K |
|
3846
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$783M
| $1.31M | ﹤0.01% |
74,731
+9,068
| +14% | +$153K |
|
3847
Fossil Group
FOSL
$349M
| $1.31M | ﹤0.01% |
282,838
+162,369
| +135% | +$623K |
|
|
GREK
3848
Global X MSCI Greece ETF
GREK
$317M
| $1.31M | ﹤0.01% |
66,375
+51,564
| +348% | +$965K |
|
3849
Envista
NVST
$4.66B
| $1.31M | ﹤0.01% |
62,086
-288,873
| -82% | -$5.42M |
|
|
DOOR
3850
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.31M | ﹤0.01% |
16,820
-17,364
| -51% | -$1.05M |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,644 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.